Company profile · Sponsor
Neuraxpharm
Neuraxpharm Pharmaceuticals S.L.
- Pipeline
- 3
- Drugs
- 0
- Patents
- 0
Quick answer
Neuraxpharm (E3E293F) is a pharma company. headquartered in Sant Joan Despí, ES. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..
Company facts
Pipeline (3)
Search pipeline →-
Levetiracetam XR, Masked Keppra® placebo film-coated tablets (a placebo tablet inside a capsule), Keppra 500 mg film-coated tablets, Levetiracetam prolonged-release placebo granules
Neuraxpharm
Refractory Partial Onset Epilepsy
1 trial -
AN OPEN LABEL, TWO PERIODS, TWO SEQUENCES, CROSSOVER, RANDOMIZED MULTIPLE DOSE BIOEQUIVALENCE STUDY OF GUANFACINE 7 MG PROLONGED-RELEASE TABLETS (TEST FORMULATION) VS. EQUAL DOSE OF INTUNIV® PROLONGED-RELEASE TABLETS (REFERENCE FORMULATION) IN HEALTHY MALE VOLUNTEERS UNDER FASTING CONDITIONS
Neuraxpharm
Study performed on healthy volunteers.
1 trial -
Safety Study to Compare the Gastrointestinal Tolerability of Oral Tegomil Fumarate and Dimethyl Fumarate (Tecfidera®) in Healthy Volunteers.
Neuraxpharm
Multiple Sclerosis
1 trial
Frequently asked questions
What is Neuraxpharm?
Neuraxpharm (E3E293F) is a pharma company. headquartered in Sant Joan Despí, ES. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..
What pipeline programs does Neuraxpharm sponsor?
We track 3 ClinicalTrials.gov-linked programs for Neuraxpharm, including Levetiracetam XR, Masked Keppra® placebo film-coated tablets (a placebo tablet inside a capsule), Keppra 500 mg film-coated tablets, Levetiracetam prolonged-release placebo granules and 2 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Neuraxpharm company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.